Market Growth and Opportunities for Anti-PD-1 Antibodies in the U.S. by 2034
The United States continues to play a pivotal role in advancing cancer immunotherapy through substantial investments in biotechnology research, clinical development, and precision medicine initiatives. Strong healthcare infrastructure and favorable regulatory pathways have accelerated the adoption of innovative antibody-based treatments across oncology settings. The country's leadership in...
0 Comments 0 Shares 182 Views 0 Reviews